Chronic allograft nephropathy in paediatric renal transplantation

Pediatric Nephrology

Volumn 22, Issue 1, 2007, Pages 17-23

  Alexander, Stephen I ^a   Fletcher, Jeffrey T ^a   Nankivell, Brian ^b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

CAN; CNI; Kidney; Protocol biopsy; Transplantation

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; EVEROLIMUS; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; RITUXIMAB; STEROID;

ACUTE GRAFT REJECTION; BONE MARROW SUPPRESSION; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE CLASSIFICATION; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; HYALINE DEGENERATION; IMMUNOPATHOLOGY; INTERSTITIAL NEPHRITIS; ISCHEMIA; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; NEPHROTOXICITY; PEDIATRIC SURGERY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846414294     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0219-y     Document Type: Review

References (67)

1. Birk PE, Stannard KM, Konrad HB, Blydt-Hansen TD, Ogborn MR, Cheang MS, Gartner JG, Gibson IW (2004) Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Pediatr Transplant 8:29-38
2. Grimm P (2004) The protocol renal allograft biopsy: Has its time come? Pediatr Transplant 8:3-5
3. Kasiske BL, Gaston RS, Gourishankar S, Halloran PF, Matas AJ, Jeffery J, Rush D (2005) Long-term deterioration of kidney allograft function. Am J Transplant 5:1405-1414
4. Isoniemi H, Taskinen E, Hayry P (1994) Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 58:1195-1198
5. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindbald AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkov K, Yamaguchi Y (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713-723
6. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Hayry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozumi K, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani R, Vonwillebrand E, Yamaguchi Y (1993) International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44:411-422
7. Feucht HE, Felber E, Gokel MJ, Hillebrand G, Nattermann U, Brockmeyer C, Held E, Riethmuller G, Land W, Albert E (1991) Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 86:464-470
8. Colvin RB (2003) Chronic allograft nephropathy. N Engl J Med 349:2288-2290
9. Nankivell BJ, Chapman JR (2006) Chronic allograft nephropathy: Current concepts and future directions. Transplantation 81:643-654
10. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR (2003) The natural history of chronic allograft nephropathy. N Engl J Med 349:2326-2333
11. Jain S, Furness PN, Nicholson ML (2000) The role of transforming growth factor beta in chronic renal allograft nephropathy. Transplantation 69:1759-1766
12. Pilmore HL, Eris JM, Painter DM, Bishop GA, McCaughan GW (1999) Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation 67:929-933
13. Melk A, Schmidt BM, Vongwiwatana A, Rayner DC, Halloran PF (2005) Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am J Transplant 5:1375-1382
14. Vongwiwatana A, Tasanarong A, Rayner DC, Melk A, Halloran PF (2005) Epithelial to mesenchymal transition during late deterioration of human kidney transplants: The role of tubular cells in fibrogenesis. Am J Transplant 5:1367-1374
15. Chapman JR, O'Connell PJ, Nankivell BJ (2005) Chronic renal allograft dysfunction. J Am Soc Nephrol 16:3015-3026
16. Bunchman TE, Fryd DS, Sibley RK, Mauer SM (1990) Manifestations of renal allograft rejection in small children receiving adult kidneys. Pediatr Nephrol 4:255-258
17. Singh A, Cortes L, Tejani A (1995) Pediatric renal transplantation. Curr Opin Nephrol Hypertens 4:478-481
18. Qvist E, Krogerus L, Laine J, Jalanko H, Ronnholm K, Salmela K, Sairanen H, Leijala M, Holmberg C (1998) Long-term follow up of renal function and histology after renal allograft transplantation in early childhood. Transpl Int 11 (Suppl 1):S39-S41
19. Birk PE, Chavers BM (1997) Does cytomegalovirus cause glomerular injury in renal allograft recipients? J Am Soc Nephrol 8:1801-1808
20. Birk PE, Matas AJ, Gillingham KJ, Mauer SM, Najarian JS, Chavers BM (1997) Risk factors for chronic rejection in pediatric renal transplant recipients-a single-center experience. Pediatr Nephrol 11:395-398
21. Tejani A, Cortes L, Stablein D (1996) Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 61:1054-1058
22. Mihatsch MJ, Ryffel B, Gudat F (1995) The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int Suppl 52:S63-S69
23. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD (2004) Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 78:557-565
24. Pascual M, Swinford RD, Ingelfinger JR, Williams WW, Cosimi AB, Tolkoff-Rubin N (1998) Chronic rejection and chronic cyclosporin toxicity in renal allografts. Immunol Today 19:514-519
25. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ (2002) Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347:103-109
26. Chadban S (2001) Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 12:394-402
27. Gallagher MP, Hall B, Craig J, Berry G, Tiller DJ, Eris J (2004) A randomized controlled trial of cyclosporine withdrawal in renal-transplant recipients: 15-year results. Transplantation 78:1653-1660
28. Rush DN, Jeffery JR, Gough J (1995) Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. Transplantation 59:511-514
29. Beveridge T, Calne RY (1995) Cyclosporine (Sandimmun) in cadaveric renal transplantation. Ten-year follow-up of a multicenter trial. European Multicentre Trial Group. Transplantation 59:1568-1570
30. Flechner SM, Kurian SM, Solez K, Cook DJ, Burke JT, Rollin H, Hammond J, Whisenant T, Lanigan C, Head S, Salomon D (2004) De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 4:1776-1785
31. Fujisawa M, Ono H, Isotani S, Higuchi A, Iijima K, Yoshiya K, Arakawa S, Matsumoto O, Nakamura H, Kamidono S, Yoshikawa N (1999) Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation. Transplant Proc 31:1687-1690
32. Filler G, Womiloju T, Feber J, Lepage N, Christians U (2005) Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure. Am J Transplant 5:2005-2010
33. Schachter AD, Meyers KE, Spaneas LD, Palmer JA, Salmanullah M, Baluarte J, Brayman KL, Harmon WE (2004) Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol. Pediatr Transplant 8:171-177
34. Dharnidharka VR, Stablein DM, Harmon WE (2004) Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS. Am J Transplant 4:384-389
35. Srivastava T, Zwick DL, Rothberg PG, Warady BA (1999) Posttransplant lymphoproliferative disorder in pediatric renal transplantation. Pediatr Nephrol 13:748-754
36. Hodson EM, Jones CA, Webster AC, Strippoli GF, Barclay PG, Kable K, Vimalachandra D, Craig JC (2005) Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: A systematic review of randomised controlled trials. Lancet 365:2105-2115
37. Ginevri F, De Santis R, Comoli P, Pastorino N, Rossi C, Botti G, Fontana I, Nocera A, Cardillo M, Ciardi MR, Locatelli F, Maccario R, Perfumo F, Azzi A (2003) Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 75:1266-1270
38. Oertel SH, Anagnostopoulos I, Bechstein WO, Liehr H, Riess HB (2000) Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: A new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid organ transplantation? Transplantation 69:430-432
39. Mannon RB (2004) Polyomavirus nephropathy: What have we learned? Transplantation 77:1313-1318
40. Nevins TE, Matas AJ (2004) Medication noncompliance: Another iceberg's tip. Transplantation 77:776-778
41. Nevins TE (2002) Non-compliance and its management in teenagers. Pediatr Transplant 6:475-479
42. Nevins TE, Kruse L, Skeans MA, Thomas W (2001) The natural history of azathioprine compliance after renal transplantation. Kidney Int 60:1565-1570
43. Cecka JM, Gjertson DW, Terasaki PI (1997) Pediatric renal transplantation: A review of the UNOS data. United Network for Organ Sharing. Pediatr Transplant 1:55-64
44. Smith JM, Ho PL, McDonald RA (2002) Renal transplant outcomes in adolescents: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 6:493-499
45. Smith JM, McDonald RA (2005) Renal transplantation in adolescents. Adolesc Med Clin 16:201-214
46. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Gough J (1994) Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 57:208-211
47. Sarwal MM, Cecka JM, Millan MT, Salvatierra O Jr (2000) Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: A single center and UNOS analysis. United Network for Organ Sharing. Transplantation 70:1728-1736
48. Qvist E, Krogerus L, Ronnholm K, Laine J, Jalanko H, Holmberg C (2000) Course of renal allograft histopathology after transplantation in early childhood. Transplantation 70:480-487
49. Rush D, Nickerson P, Gough J, McKenna R, Grimm P, Cheang M, Trpkov K, Solez K, Jeffery J (1998) Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 9:2129-2134
50. Shishido S, Asanuma H, Nakai H, Mori Y, Satoh H, Kamimaki I, Hataya H, Ideda M, Honda M, Hasegawa A (2003) The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 14:1046-1052
51. Kamimaki I, Shishido S, Ikeda M, Honda M (2002) Histopathological findings of 10-year protocol biopsy in pediatric kidney transplant recipients. Transplant Proc 34:3130-3131
52. Benamenyo JP, Droz D, Niaudet P (2001) One-year routine renal transplant biopsies in children. Pediatr Nephrol 16:971-977
53. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, Salvatierra O Jr (2003) Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 349:125-138
54. Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, Nicolle L, Karpinski M, Jeffery J, Nickerson P (2004) Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 15:219-227
55. Sarwal M (2006) Steroid elimination is coming of age. Pediatr Nephrol 21:2-4
56. Webster AC, Playford EG, Higgins G, Chapman JR, Craig JC (2004) Interleukin 2 receptor antagonists for renal transplant recipients: A meta-analysis of randomized trials. Transplantation 77:166-176
57. Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF, Rapamune Maintenance Regimen Trial (2004) Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol 15:809-817
58. Ibanez JP, Monteverde ML, Goldberg J, Diaz MA, Turconi A (2005) Sirolimus in pediatric renal transplantation. Transplant Proc 37:682-684
59. Butani L (2004) Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue. Transplantation 78:1362-1366
60. Mulay AV, Hussain N, Fergusson D, Knoll GA (2005) Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: A systematic review of randomized trials. Am J Transplant 5:1748-1756
61. Russ G, Segoloni G, Oberbauer R, Legendre C, Mota A, Eris J, Grinyo JM, Friend P, Lawen J, Hartmann A, Schena FP, Lelong M, Burke JT, Neylan JF, for the Rapamune Maintenance Regimen Study Group (2005) Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function. Transplantation 80:1204-1211
62. Mota A, Arias M, Taskinen EI, Paavonen T, Brault Y, Legendre C, Claesson K, Castagneto M, Campistol JM, Hutchison B, Burke JT, Yilmaz S, Hayry P, Neylan JF, Ramamune Maintenance Regimen Trial (2004) Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 4:953-961
63. Hoyer PF, Ettenger R, Kovarik JM, Webb NJ, Lemire J, Mentser M, Mahan J, Loirat C, Niaudet P, VanDamme-Lombaerts R, Offner G, Wehr S, Moeller V, Mayer H, Everolimus Pediatric Study Group (2003) Everolimus in pediatric de nova renal transplant patients. Transplantation 75:2082-2085
64. Krieger NR, Emre S (2004) Novel immunosuppressants. Pediatr Transplant 8:594-599
65. Bartosh SM, Knechtle SJ, Sollinger HW (2005) Campath-1H use in pediatric renal transplantation. Am J Transplant 5:1569-1573
66. Elster EA, Hale DA, Mannon RB, Cendales LC, Swanson SJ, Kirk AD (2004) The road to tolerance: Renal transplant tolerance induction in nonhuman primate studies and clinical trials. Transpl Immunol 13:87-99
67. Cosimi AB, Sachs DH (2004) Mixed chimerism and transplantation tolerance. Transplantation 77:943-946